Correlation Between Macquarie Group and Medical Developments

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Macquarie Group and Medical Developments at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Macquarie Group and Medical Developments into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Macquarie Group Ltd and Medical Developments International, you can compare the effects of market volatilities on Macquarie Group and Medical Developments and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Macquarie Group with a short position of Medical Developments. Check out your portfolio center. Please also check ongoing floating volatility patterns of Macquarie Group and Medical Developments.

Diversification Opportunities for Macquarie Group and Medical Developments

-0.58
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Macquarie and Medical is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Macquarie Group Ltd and Medical Developments Internati in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medical Developments and Macquarie Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Macquarie Group Ltd are associated (or correlated) with Medical Developments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medical Developments has no effect on the direction of Macquarie Group i.e., Macquarie Group and Medical Developments go up and down completely randomly.

Pair Corralation between Macquarie Group and Medical Developments

Assuming the 90 days trading horizon Macquarie Group Ltd is expected to generate 0.1 times more return on investment than Medical Developments. However, Macquarie Group Ltd is 10.36 times less risky than Medical Developments. It trades about 0.05 of its potential returns per unit of risk. Medical Developments International is currently generating about -0.04 per unit of risk. If you would invest  9,359  in Macquarie Group Ltd on September 14, 2024 and sell it today you would earn a total of  1,041  from holding Macquarie Group Ltd or generate 11.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Macquarie Group Ltd  vs.  Medical Developments Internati

 Performance 
       Timeline  
Macquarie Group 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Macquarie Group Ltd are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Macquarie Group is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Medical Developments 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medical Developments International has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Macquarie Group and Medical Developments Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Macquarie Group and Medical Developments

The main advantage of trading using opposite Macquarie Group and Medical Developments positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Macquarie Group position performs unexpectedly, Medical Developments can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medical Developments will offset losses from the drop in Medical Developments' long position.
The idea behind Macquarie Group Ltd and Medical Developments International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stocks Directory
Find actively traded stocks across global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum